Vertaling van "collaboration with various parties concerned " (Nederlands → Frans) :

A text is being prepared within the FAMHP in collaboration with various parties concerned which will enable a realistic approach to be adopted.
A text is being prepared within the FAMHP in collaboration with various parties concerned which will enable a realistic approach to be adopted.

The BUM department collects and circulates relevant information about medicines on behalf of the various parties concerned.
The BUM department collects and circulates relevant information about medicines on behalf of the various parties concerned.

It is therefore desirable that the various parties involved should collaborate with each other in order to adjust the care provided in the best way possible.
La collaboration entre les différents acteurs est donc souhaitable afin d’accorder les soins le mieux possible.

A “living” manual will describe the various communication actions, the parties concerned and the role of each one.
A “living” manual will describe the various communication actions, the parties concerned and the role of each one.

Working together with the hospitals belonging to the group shows that the various parties involved benefit from it:
La pratique de partenariat avec les hôpitaux du groupe met en évidence plusieurs avantages pour les différents acteurs:

Current practice in Flanders is assessed by means of interviews, which will be conducted with various occupational groups (GPs, pharmacists, CGG staff, telephone help line staff…) as well as students. In some groups a measurement is made before and after the training programmes on suicide, in collaboration with the Centrum ter Preventie van Zelfmoord (CPZ), which organises several trainings on this topic.
Chez certains groupes, une mesure est effectuée avant et après les programmes de formation concernant le suicide, en collaboration avec le Centrum ter Preventie van Zelfmoord (CPZ), qui organise diverses formations sur ce thème.

Various roadshows were organised in order to inform the FAMHP stakeholders about this new activity within the FAMHP and to provide a coherent explanation of recent regulations regarding medicines for veterinary use and the distribution of these products in particular; the roadshows were organised for and in collaboration with the veterinarian professional organisations.
Various roadshows were organised in order to inform the FAMHP stakeholders about this new activity within the FAMHP and to provide a coherent explanation of recent regulations regarding medicines for veterinary use and the distribution of these products in particular; the roadshows were organised for and in collaboration with the veterinarian professional organisations.

The Clinical Trial Facilitation Group (CTFG) is a collaborative effort to facilitate and harmonise clinical trials in Europe. Within the CTFG agreements have been made for various competent authorities to voluntarily arrive at a common evaluation for applications for clinical trials whenever this involves multicentre trials with participating centres from different Member States.
The Clinical Trial Facilitation Group (CTFG) is a collaborative effort to facilitate and harmonise clinical trials in Europe. Within the CTFG agreements have been made for various competent authorities to voluntarily arrive at a common evaluation for applications for clinical trials whenever this involves multicentre trials with participating centres from different Member States.

Training has been offered in the various regions in collaboration with the partners and will be embedded as much as possible in local training structures.
En collaboration avec les partenaires, des formations seront offertes dans les différentes régions, et dans la mesure du possible, ces formations seront également ancrées dans les structures de formation locales.

As for D-glucuronolactone, the group believes that this concerns a normal human metabolite deriving from glucose, which does not involve a structural risk with regard to mutagenicity or carcinogenicity. It also holds that both this component as well as its hydrolysis product, glucuronic acid, are endogenous metabolites in humans and other mammals, that they are naturally present in various food sources and that they are quickly metabolised into innocuous products and excreted.
Pour la D-glucuronolactone, le groupe considère qu’il s’agit d’un métabolite humain normal provenant du glucose qui ne présente pas de risque structural en termes de mutagénicité ou de carcinogénicité, que pour ce composant, comme pour son produit d’hydrolyse, l’acide glucuronique, il s’agit de métabolites endogènes chez l’homme et les autres mammifères, qu’ils se trouvent à l’état naturel dans diverses sources alimentaires et qu’ils sont rapidement métabolisés en produits sans danger et excrétés.